Idiopathic Pulmonary Fibrosis: Health Services

Department of Health and Social Care written question – answered on 6th January 2021.

Alert me about debates like this

Photo of Lord McCrea of Magherafelt and Cookstown Lord McCrea of Magherafelt and Cookstown DUP

To ask Her Majesty's Government what support they are providing to pulmonary fibrosis patients whose treatment was disrupted during the COVID-19 pandemic.

Photo of Lord Bethell Lord Bethell The Parliamentary Under-Secretary for Health and Social Care

At the peak of the COVID-19 pandemic some clinics were suspended but rapidly reinstated and recommendations to continue specialised clinic work in the second wave has been issued. Patients have continued to be both identified and treated.

While such lung function measurements are aerosol generating procedures, advice was circulated by The Association for Respiratory Technology and Physiology to ensure such patients were investigated.

For those patients already receiving treatment the National Institute for Health and Care Excellence guidelines were relaxed to ensure continuation of the drugs and to allow initiation of new therapies.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.